Vapotherm, Inc. Soared

Vapotherm, Inc. (VAPO:NYSE) rocketted at $0.74, representing a gain of 30.2%. On Fri, Nov 25, 2022, VAPO:NYSE hit a New 2-Week High of $0.74. The stock got featured on our News Catalysts scanner on Tue, Nov 22, 2022 at 07:49 AM in the 'AGREEMENT' category. From Fri, Nov 11, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days
About Vapotherm, Inc. (VAPO:NYSE)
Vapotherm Inc is a medical technology company based in the United States. It is mainly engaged in the development and commercialization of its proprietary Hi-VNI technology products that are used to treat patients of all ages suffering from respiratory distress. The company offers three versions of its Precision Flow systems: Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. It generates revenue primarily from sales of proprietary Precision Flow systems to hospitals through a direct sales organization in the United States and through distributors in select countries outside of the United States.
Top 10 Gainers:
- FedNat Holding Company (FNHC:NASDAQ), 94.71%
- AEye Inc. (LIDR:NASDAQ), 50.02%
- Euda Health Holdings Ltd Ord Shs (EUDA:NASDAQ), 37.04%
- Peak Bio Inc Com (PKBO:NASDAQ), 36.84%
- Kidpik Corp. (PIK:NASDAQ), 36.75%
- Expion360 Inc. (XPON:NASDAQ), 36.1%
- VEON Ltd. (VEON:NASDAQ), 31.14%
- Vapotherm, Inc. (VAPO:NYSE), 30.18%
- Cognition Therapeutics Inc. (CGTX:NASDAQ), 28.5%
- Super League Gaming, Inc. (SLGG:NASDAQ), 24.27%